Genovis rights issue oversubscribed

4/22/2013 5:17 AM EST

The issue was subscribed for SEK 15,129, 289, which it was oversubscribed by 10%.
Of the total issue volume of 3,945,189 shares, 77% were subscribed for with preferential rights. The rights issue raised about SEK 13.8 million before issue expenses for Genovis. Statements of account will be sent on April 23, 2013, to allot shares subscribed for without preferential rights.

INTERIM REPORT JANUARY – MARCH 2013

4/16/2013 2:10 AM EST

January–March · Net sales increased by 102 percent to SEK 1,906k (944k). · Loss after financial items was SEK 3,957k (loss: 4,008k). · Comprehensive income was a loss of...

Genovis to publish Q1 2013 report ahead of schedule

4/10/2013 6:42 AM EST

The Interim Report for January-March, which was to be announced on April 24, will be published ahead of schedule. The new publication date for the report is April 16, 2013.

Genovis’ 2012 Annual Report Published

4/9/2013 7:59 AM EST

Genovis’ 2012 annual report has been published and is available on the Genovis website on the page with financial reports, as well as the page with documents for the 2013 annual...

Genovis receives SEK 1.575 million from VINNOVA

3/26/2013 6:21 AM EST

VINNOVA (Swedish Agency for Innovation Systems) chose to support the project “Nanoparticles in movement serve as contrast agents in medical ultrasound,” which Genovis runs...

Notice of Annual General Meeting of Genovis AB (publ)

3/21/2013 7:10 AM EST

Shareholders of GENOVIS AB (publ) are hereby summoned to the Annual General Meeting (“the Meeting”) to be held on Thursday, April 25, 2013, at 5:00 p.m. at Scheelevägen 22, Lund,...

Genovis signs agreement on projects for major pharmaceutical company

3/20/2013 5:44 AM EST

The one-year development project agreement on behalf of a customer is worth about USD 100,000. The project will adapt Genovis’ products from the protein characterization portfolio...

YEAR-END REPORT JANUARY-DECEMBER 2012

2/28/2013 3:52 AM EST

Fourth quarter 2012 (compared with the same period 2011) · Net sales increased by 88% to SEK 2,017k (1,071k). · Operating loss before depreciation, amortization and...

Genovis’ Board of Directors decides on rights issue

2/19/2013 5:47 AM EST

Sales of products from Genovis’ protein engineering portfolio have shown a steady increase of about 100% percent annually. Genovis aims to maintain this growth rate during 2013...

Continued strong sales in third quarter

11/13/2012 4:46 AM EST

Third quarter 2012 (compared with the same period 2011) · Net sales increased by 152% to SEK 1,972k (784k). · Loss...

Genovis to publish Q3 2012 report ahead of schedule

11/8/2012 4:49 AM EST

The Board of Directors of Genovis AB (publ) has decided to publish Q3 2012 report ahead of schedule.
The Interim Report for January-September, which was to be announced on...

HALF-YEARLY REPORT JANUARY-JUNE 2012

8/29/2012 3:46 AM EST

· Net sales rose to SEK 2,092k (1,030k), up 103% compared with the same period in 2011. · Loss after financial...

Genovis strengthens organization with international sales manager

7/3/2012 5:00 AM EST

Susanne Olauson has been appointed to be sales manager at Genovis. She joins us most recently from Redsense Medical,...

Genovis Signs Exclusive Distribution Agreement with Sigma-Aldrich® for Sales in Asia, Southeast Asia and South America

6/29/2012 3:56 AM EST

Genovis announced today that it has signed an exclusive distribution agreement with Sigma-Aldrich Corporation (NASDAQ: SIAL) that enables the sale...

Genovis completes private placement of shares to LMK Venture AB

5/28/2012 6:44 AM EST

Genovis has carried out a rights issue of 1 450 000 shares, thereby increasing share capital by SEK 580 000.
The issue is directed at LMK Venture AB with deviation from...

Genovis’ rights issue fully subscribed

5/22/2012 5:09 AM EST

Genovis’ rights issue is fully subscribed and 81% of the shares are subscribed with preferential rights. The rights issue raised about SEK 12.1 million before issue expenses for...

Genovis launches FabRICATOR® 96-well plate for high throughput applications

5/21/2012 3:59 AM EST

Genovis is launching the FabRICATOR 96-well plate at the 2012 ASMS conference (May 19-24) in Vancouver, Canada, and the ADC Summit 2012 (May 23-24) conference in London.

Genovis to publish Q2 2012 report ahead of schedule

5/18/2012 4:17 AM EST

The Board of Directors of Genovis AB (publ) has decided to publish Q2 2012 report ahead of schedule.

The Interim Report for January-June, which was to be announced on September...

INTERIM REPORT January – March 2012

4/25/2012 3:48 AM EST

Net sales totaled SEK 944k (455k), which is an increase of 107% compared with the first quarter of 2011. Loss after...

Genovis to publish Q1 2012 report ahead of schedule

4/23/2012 4:49 AM EST

Genovis has decided to publish the report for Q1 2012 on Wednesday, April 25.
The subscription period for Genovis’ rights issue is April 25 – May 10. Consequently, the Board...

Genovis publish a new share issue prospectus

3/28/2012 5:43 AM EST

Finansinspektionen (the Swedish Financial Supervisory Authority) approved on March 28 Genovis prospectus for a new share issue with preference for existing shareholders, the...

Genovis AB

facebook youtube youtube RSS

The Group consists of Genovis AB and the fully owned subsidiary Eijdo research AB. Genovis develops and sells innovative technologies from two unique product portfolios. The first involves nanotechnology in new contrast ...

CONTACT

Genovis AB
+46 (0)46 10 12 30
http://www.genovis.com/

Media

Sarah Fredriksson, CEO comments the Year-End Report 2011

Sarah Fredriksson, CEO comments the interim report

Social

Genovis rights issue oversubscribed

4/22/2013 5:17 AM EST

Genovis rights issue oversubscribed

Genovis rights issue oversubscribed
news.cision.com
The issue was subscribed for SEK 15,129, 289, which it was oversubscribed by 10%. Of the total issue volume of 3,945,189 shares, 77% were subscribed for with preferential rights. The rights issue raised about SEK 13.8 million before issue...

http://www.sydsvenskan.se/ekonomi/dubblad-forsaljning-for-genovis/

4/17/2013 7:28 AM EST

http://www.sydsvenskan.se/ekonomi/dubblad-forsaljning-for-genovis/

Dubblad försäljning för Genovis
www.sydsvenskan.se
Enzymer är ett relativt nytt affärsområde för Genovis, bolaget inledde enzymförsäljningen i slutet av 2010 och affärerna har vuxit snabbt. Köparna...

INTERIM REPORT JANUARY – MARCH 2013

4/16/2013 2:10 AM EST

INTERIM REPORT JANUARY – MARCH 2013

INTERIM REPORT JANUARY – MARCH 2013
news.cision.com
January–March · Net sales increased by 102 percent to SEK 1,906k (944k). · Loss after financial items was SEK 3,957k (loss: 4,008k). · Comprehensive income was a loss of SEK 3,946k (loss: 3,970k). · Comprehensive income per share basic...

Genovis to publish Q1 2013 report ahead of schedule

4/10/2013 6:42 AM EST

Genovis to publish Q1 2013 report ahead of schedule

Genovis to publish Q1 2013 report ahead of schedule
news.cision.com
The Interim Report for January-March, which was to be announced on April 24, will be published ahead of schedule. The new publication date for the report is April 16, 2013.

Genovis’ 2012 Annual Report Published

4/9/2013 8:00 AM EST

Genovis’ 2012 Annual Report Published

Genovis’ 2012 Annual Report Published
news.cision.com
Genovis’ 2012 annual report has been published and is available on the Genovis website on the page with financial reports, as well as the page with documents for the 2013 annual general meeting. The English version of the annual report is expected...

Genovis receives SEK 1.575 million from VINNOVA

3/26/2013 6:21 AM EST

Genovis receives SEK 1.575 million from VINNOVA

Genovis receives SEK 1.575 million from VINNOVA
news.cision.com
VINNOVA (Swedish Agency for Innovation Systems) chose to support the project “Nanoparticles in movement serve as contrast agents in medical ultrasound,” which Genovis runs together with Associate Professor Tomas Jansson’s research group at the...

Årsstämma i Genovis AB (publ)

3/21/2013 6:46 AM EST

Årsstämma i Genovis AB (publ)

Årsstämma i Genovis AB (publ)
news.cision.com
Aktieägare i Genovis AB (publ) kallas härmed till årsstämma torsdagen den 25 april 2013 Klockan 17:00, Scheelevägen 22 i Lund. 16.30 – 17.00 Registrering 17.00 Årsstämman inleds Efter stämman serveras en lättare förtäring Förslag till...

Genovis signs agreement on projects for major pharmaceutical company

3/20/2013 5:44 AM EST

Genovis signs agreement on projects for major pharmaceutical company

Genovis signs agreement on projects for major pharmaceutical company
news.cision.com
The one-year development project agreement on behalf of a customer is worth about USD 100,000. The project will adapt Genovis’ products from the protein characterization portfolio to the customer’s technology platform.

YEAR-END REPORT JANUARY-DECEMBER 2012

2/28/2013 3:53 AM EST

YEAR-END REPORT JANUARY-DECEMBER 2012

YEAR-END REPORT JANUARY-DECEMBER 2012
news.cision.com
Fourth quarter 2012 (compared with the same period 2011) · Net sales increased by 88% to SEK 2,017k (1,071k). · Operating loss before depreciation, amortization and impairment was SEK 4,335k (loss: 3,333k). · Loss after financial items was...

BOKSLUTSRAPPORT januari - december 2012

2/28/2013 3:18 AM EST

BOKSLUTSRAPPORT januari - december 2012

BOKSLUTSRAPPORT januari - december 2012
news.cision.com
Fjärde kvartalet 2012 (jämfört med samma period föregående år) · Nettoomsättningen ökade med 88 % till 2 017 (1 071) kSEK. · Rörelseresultat före avskrivningar uppgick till -4 335 (-3 333) kSEK. · Resultatet efter finansnetto uppgick till -8...

Our web site is being updated. During that time the site will not be available....

1/21/2013 5:34 AM EST

Our web site is being updated. During that time the site will not be available.

Thank you for your patience.

Many delegates came to hear Sarah Fredriksson at the European Antibody Congress...

11/29/2012 9:52 AM EST

Many delegates came to hear Sarah Fredriksson at the European Antibody Congress in Geneva.

Hemsidan funkar igen!

11/22/2012 6:48 PM EST

Hemsidan funkar igen!

Vi har sedan några timmar tillbaka problem med vår hemsida. Det beror på ett pro...

11/22/2012 4:08 PM EST

Vi har sedan några timmar tillbaka problem med vår hemsida. Det beror på ett problem hos vår leverantör som arbetar med att lösa problemet. För närvarande finns ingen uppskattad tid när problemet är löst.

Continued strong sales in third quarter

11/13/2012 4:46 AM EST

Continued strong sales in third quarter

Continued strong sales in third quarter
www.cisionwire.com
Third quarter 2012 (compared with the same period 2011) · Net sales increased by 152% to SEK 1,972k (784k). · Loss after financial items was SEK 3,259k (loss: 3,018k). · Comprehensive income per share basic and diluted totaled SEK -0.27...

Genovis to publish Q3 2012 report ahead of schedule

11/8/2012 4:49 AM EST

Genovis to publish Q3 2012 report ahead of schedule

Genovis to publish Q3 2012 report ahead of schedule
www.cisionwire.com
The Board of Directors of Genovis AB (publ) has decided to publish Q3 2012 report ahead of schedule. The Interim Report for January-September, which was to be announced on November 14, will be published ahead of schedule. The new publication...

Fullt hus hos Aktiespararna i Staffanstorp när Sarah Fredriksson presenterade Ge...

9/18/2012 4:02 PM EST

Fullt hus hos Aktiespararna i Staffanstorp när Sarah Fredriksson presenterade Genovis.

First day at the CASSS meeting Practical Applications of Mass Spectrometry in th...

9/12/2012 3:08 PM EST

First day at the CASSS meeting Practical Applications of Mass Spectrometry in the Biotechnology Industry! FabRICATOR and IgGZERO are becoming more well known and we are enjoying the presentations and poster sessions.

Thanks to all WMIC delegates for an inspiring conference and a great week in Dub...

9/12/2012 3:05 PM EST

Thanks to all WMIC delegates for an inspiring conference and a great week in Dublin!

HALF-YEARLY REPORT JANUARY-JUNE 2012

8/29/2012 3:46 AM EST

HALF-YEARLY REPORT JANUARY-JUNE 2012

HALF-YEARLY REPORT JANUARY-JUNE 2012
www.cisionwire.com
· Net sales rose to SEK 2,092k (1,030k), up 103% compared with the same period in 2011. · Loss after financial items was SEK k 8,438 (loss: SEK 6,784k). · Comprehensive income per share, based on a weighted average of the number of...

Genovis strengthens organization with international sales manager

7/3/2012 5:01 AM EST

Genovis strengthens organization with international sales manager

Genovis strengthens organization with international sales manager
www.cisionwire.com
Susanne Olauson has been appointed to be sales manager at Genovis. She joins us most recently from Redsense Medical, where she worked since 2007 in sales and marketing in the US, European and Australian markets.

Genovis Signs Exclusive Distribution Agreement with Sigma-Aldrich® for Sales in...

6/29/2012 3:57 AM EST

Genovis Signs Exclusive Distribution Agreement with Sigma-Aldrich® for Sales in Asia, Southeast Asia and South America

Genovis Signs Exclusive Distribution Agreement with Sigma-Aldrich® for Sales in Asia, Southeast Asia
www.cisionwire.com
Genovis announced today that it has signed an exclusive distribution agreement with Sigma-Aldrich Corporation (NASDAQ: SIAL) that enables the sale of Genovis products in about 50 countries across Asia, Southeast Asia...

På väg till Stockholm för att presentera Genovis på Småbolagsdagen!

6/4/2012 5:18 AM EST

På väg till Stockholm för att presentera Genovis på Småbolagsdagen!

Genovis completes private placement of shares to LMK Venture AB

5/28/2012 6:46 AM EST

Genovis completes private placement of shares to LMK Venture AB

Genovis completes private placement of shares to LMK Venture AB
www.cisionwire.com
Genovis has carried out a rights issue of 1 450 000 shares, thereby increasing share capital by SEK 580 000. The issue is directed at LMK Venture AB with deviation from shareholders’ preferential rights. The issue was authorized by the annual...

Genovis’ rights issue fully subscribed

5/22/2012 5:11 AM EST

Genovis’ rights issue fully subscribed

Genovis’ rights issue fully subscribed
www.cisionwire.com
Genovis’ rights issue is fully subscribed and 81% of the shares are subscribed with preferential rights. The rights issue raised about SEK 12.1 million before issue expenses for Genovis. Statements of account will be sent on May 22, 2012, to allot...

Genovis launches FabRICATOR® 96-well plate for high throughput applications

5/21/2012 4:00 AM EST

Genovis launches FabRICATOR® 96-well plate for high throughput applications

Genovis launches FabRICATOR® 96-well plate for high throughput applications
www.cisionwire.com
Genovis is launching the FabRICATOR 96-well plate at the 2012 ASMS conference (May 19-24) in Vancouver, Canada, and the ADC Summit 2012 (May 23-24) conference in London. The FabRICATOR 96-well plate is standard format and fits most robotic...